Nektar Therapeutics (NKTR)
Develops investigational immune-modulating medicines for autoimmune disease and cancer.
$61.45
After hours+0.51 (+0.84%)
At close$60.94(−8.83%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$2.13
Revenue estimate
$10.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.45−$3.60−$2.95−$1.85−$1.78−$1.82−$1.23Pending
Estimate−$0.18−$2.56−$3.03−$2.85−$2.47−$1.58−$1.97−$2.13
Surprise+350.0%−40.4%+2.6%+35.1%+28.1%−15.0%+37.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$29.2M$10.5M$11.2M$11.8M$21.8M$10.9M$10.1MPending
Estimate$35.5M$15.4M$9.5M$10.1M$10.2M$10.7M$10.4M$10.4M
Surprise−17.8%−31.9%+17.8%+17.3%+114.0%+1.6%−2.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | −$3.38 | — | — |
| Sep 2029 | −$3.36 | — | — |
| Jun 2029 | −$3.61 | — | — |
| Mar 2029 | −$3.54 | — | — |
| Dec 2028 | −$3.85 | — | — |
| Sep 2028 | −$4.13 | — | — |
| Jun 2028 | −$4.48 | — | — |
| Mar 2028 | −$4.64 | — | — |
| Dec 2027 | −$2.94 | — | — |
| Sep 2027 | −$3.02 | — | — |
| Jun 2027 | −$2.80 | — | — |
| Mar 2027 | −$2.85 | — | — |
| Dec 2026 | −$2.74 | — | — |
| Nov 2026 | −$2.13 | — | — |
| Aug 2026 | −$1.97 | −$1.23 | +37.6% |
| May 2026 | −$1.58 | −$1.82 | −15.0% |
| Mar 2026 | −$2.47 | −$1.78 | +28.1% |
| Nov 2025 | −$2.85 | −$1.85 | +35.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | −$3.38 | — | — | $10.9M | — | — | — |
| Sep 2029 | −$3.36 | — | — | $10.9M | — | — | — |
| Jun 2029 | −$3.61 | — | — | $10.9M | — | — | — |
| Mar 2029 | −$3.54 | — | — | $10.9M | — | — | — |
| Dec 2028 | −$3.85 | — | — | $10.7M | — | — | — |
| Sep 2028 | −$4.13 | — | — | $10.7M | — | — | — |
| Jun 2028 | −$4.48 | — | — | $10.7M | — | — | — |
| Mar 2028 | −$4.64 | — | — | $10.7M | — | — | — |
| Dec 2027 | −$2.94 | — | — | $8.2M | — | — | — |
| Sep 2027 | −$3.02 | — | — | $8.3M | — | — | — |
| Jun 2027 | −$2.80 | — | — | $10.1M | — | — | — |
| Mar 2027 | −$2.85 | — | — | $10.3M | — | — | — |
| Dec 2026 | −$2.74 | — | — | $10.5M | — | — | — |
| Nov 5, 2026 | −$2.13 | — | — | $10.4M | — | — | — |
| Aug 13, 2026 | −$1.97 | −$1.23 | +37.6% | $10.4M | $10.1M | −2.8% | −3.8% |
| May 7, 2026 | −$1.58 | −$1.82 | −15.0% | $10.7M | $10.9M | +1.6% | −1.8% |
| Mar 12, 2026 | −$2.47 | −$1.78 | +28.1% | $10.2M | $21.8M | +114.0% | +4.1% |
| Nov 6, 2025 | −$2.85 | −$1.85 | +35.1% | $10.1M | $11.8M | +17.3% | +1.5% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 12, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 4, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 3, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 5, 2015 |